Vitamin D receptor is a novel drug target for ovarian cancer treatment.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Current Cancer Drug Targets

• Publication date

  2006-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/156800906776842939PMID 16712459
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunohistochemical detection and distribution of the 1,25-dihydroxyvitamin D3 receptor in rat reproductive tissues

  2005cited by this paper
• Growth suppression of ovarian cancer xenografts in nude mice by vitamin D analogue EB1089.

  2005cited by this paper
• 1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer.

  2005cited by this paper
• Combined effect of vitamin D3 analogs and paclitaxel on the growth of MCF-7 breast cancer cells in vivo

  2004cited by this paper
• Combination therapy to treat moderate to severe psoriasis.

  2004cited by this paper
• Role of 24‐hydroxylase in vitamin D3 growth response of OVCAR‐3 ovarian cancer cells

  2004cited by this paper
• Vitamin D Receptor and p21/WAF1 Are Targets of Genistein and 1,25-Dihydroxyvitamin D3 in Human Prostate Cancer Cells

  2004cited by this paper
• Anti-tumor activity of calcitriol: pre-clinical and clinical studies.

  2004cited by this paper
• Beginning to understand the end of the chromosome.

  2004cited by this paper
• p27Kip1 Stabilization and G1 Arrest by 1,25-Dihydroxyvitamin D3 in Ovarian Cancer Cells Mediated through Down-regulation of Cyclin E/Cyclin-dependent Kinase 2 and Skp1-Cullin-F-box Protein/Skp2 Ubiquitin Ligase*

  2004cited by this paper
• Induction of Ovarian Cancer Cell Apoptosis by 1,25-Dihydroxyvitamin D3 through the Down-regulation of Telomerase*

  2004cited by this paper
• Nutrition. The vitamin D deficit.

  2003cited by this paper
• A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma

  2003cited by this paper
• Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma.

  2003cited by this paper
• Genistein inhibits vitamin D hydroxylases CYP24 and CYP27B1 expression in prostate cells.

  2003cited by this paper
• Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma.

  2003cited by this paper
• Vitamin D: A millenium perspective

  2003cited by this paper
• Combination treatment with 1alpha,25-dihydroxyvitamin D3 and 9-cis-retinoic acid directly inhibits human telomerase reverse transcriptase transcription in prostate cancer cells.

  2003cited by this paper
• Overexpression of p21, cyclin E and decreased expression of p27 in DMBA (7, 12‐dimethylbenzanthracene)‐induced rat ovarian carcinogenesis

  2003cited by this paper
• Carcinoma of the ovary

  2003cited by this paper
• Evaluation of vitamin D analogs as therapeutic agents for prostate cancer.

  2003cited by this paper
• Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.

  2003cited by this paper
• New insights into the mechanisms of vitamin D action

  2003cited by this paper
• G2/M Arrest by 1,25-Dihydroxyvitamin D3 in Ovarian Cancer Cells Mediated through the Induction of GADD45 via an Exonic Enhancer*

  2003cited by this paper
• Physical and Functional Interaction between the Vitamin D Receptor and Hairless Corepressor, Two Proteins Required for Hair Cycling*

  2003cited by this paper
• New clues about vitamin D functions in the nervous system.

  2002cited by this paper
• Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways.

  2002cited by this paper
• Genistein and vitamin D synergistically inhibit human prostatic epithelial cell growth.

  2002cited by this paper
• A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer

  2002cited by this paper
• The significance of telomerase activation and cellular immortalization in human cancer.

  2002cited by this paper
• Expression of Human Telomerase (hTERT) Does Not Prevent Stress-induced Senescence in Normal Human Fibroblasts but Protects the Cells from Stress-induced Apoptosis and Necrosis*

  2002cited by this paper
• GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity

  2002cited by this paper
• Vitamin D and Its Analog EB1089 Induce p27 Accumulation and Diminish Association of p27 with Skp2 Independent of PTEN in Pituitary Corticotroph Cells

  2002cited by this paper
• Immunohistochemical analysis of 1,25-dihydroxyvitamin-D3-receptors, estrogen and progesterone receptors and Ki-67 in ovarian carcinoma.

  2002cited by this paper
• Nutritional Determinants of Epithelial Ovarian Cancer Risk: A Case-Control Study in Mexico

  2002cited by this paper
• Vitamin D Receptor As an Intestinal Bile Acid Sensor

  2002cited by this paper
• Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling.

  2001cited by this paper
• Vitamin D: its role and uses in immunology 1

  2001cited by this paper
• Vitamin D and genomic stability.

  2001cited by this paper
• Dimethylbenzanthracene carcinogenesis in Gadd45a-null mice is associated with decreased DNA repair and increased mutation frequency.

  2001cited by this paper
• Expression of telomerase inhibits hydroxyl radical‐induced apoptosis in normal telomerase negative human lung fibroblasts

  2001cited by this paper
• A Phase I trial of pulse calcitriol in patients with refractory malignancies

  2001cited by this paper
• Nuclear receptors and lipid physiology: opening the X-files.

  2001cited by this paper
• Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis.

  2001cited by this paper
• Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells.

  2001cited by this paper
• Underexpression of cyclin-dependent kinase inhibitor p27 is associated with poor prognosis in serous ovarian carcinomas.

  2001cited by this paper
• The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function

  2000cited by this paper
• Vitamin D and prostate cancer.

  2000cited by this paper
• p27Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis.

  2000cited by this paper
• A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice.

  2000cited by this paper
• BRCA1 activation of the GADD45 promoter

  2000cited by this paper
• The Pezcoller lecture: cancer cell cycles revisited.

  2000cited by this paper
• 1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo.

  2000cited by this paper
• Androgen receptor and vitamin D receptor in human ovarian cancer: Growth stimulation and inhibition by ligands

  2000cited by this paper
• The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand.

  2000cited by this paper
• Mechanisms of gene regulation by vitamin D(3) receptor: a network of coactivator interactions.

  2000cited by this paper
• Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors

  1999cited by this paper
• Creation of human tumour cells with defined genetic elements

  1999cited by this paper
• Gadd45, a p53-Responsive Stress Protein, Modifies DNA Accessibility on Damaged Chromatin

  1999cited by this paper
• 1Alpha,25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines.

  1999cited by this paper
• Genomic instability in Gadd45a-deficient mice

  1999cited by this paper
• GADD45 induction of a G2/M cell cycle checkpoint.

  1999cited by this paper
• Telomere shortening and apoptosis in telomerase-inhibited human tumor cells.

  1999cited by this paper
• Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.

  1999cited by this paper
• Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45

  1999cited by this paper
• Differential telomerase activity, expression of the telomerase catalytic sub‐unit and telomerase‐RNA in ovarian tumors

  1999cited by this paper
• Alien, a Highly Conserved Protein with Characteristics of a Corepressor for Members of the Nuclear Hormone Receptor Superfamily

  1999cited by this paper
• Inhibition of telomerase limits the growth of human cancer cells

  1999cited by this paper
• Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21

  1999cited by this paper
• Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer.

  1999cited by this paper
• A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy.

  1999cited by this paper
• Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograft.

  1998cited by this paper
• A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer.

  1998cited by this paper
• Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone.

  1998cited by this paper
• Vitamin D receptor gene polymorphism is associated with metastatic breast cancer.

  1998cited by this paper
• c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets.

  1998cited by this paper
• Extension of life-span by introduction of telomerase into normal human cells.

  1998cited by this paper
• Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089.

  1998cited by this paper
• Myc suppresses induction of the growth arrest genes gadd34, gadd45, and gadd153 by DNA-damaging agents

  1998cited by this paper
• Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization.

  1998cited by this paper
• 1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1.

  1997cited by this paper
• Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.

  1997cited by this paper
• Steroid receptor coactivator-1 is a histone acetyltransferase

  1997cited by this paper
• Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells in vivo and in vitro.

  1997cited by this paper
• Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.

  1996cited by this paper
• Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors

  1996cited by this paper
• Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway.

  1996cited by this paper
• A transcriptional co-repressor that interacts with nuclear hormone receptors

  1995cited by this paper
• Inhibitors of mammalian G1 cyclin-dependent kinases.

  1995cited by this paper
• Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily

  1995cited by this paper
• Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor

  1995cited by this paper
• Evolutionary importance for the membrane enhancement of the production of vitamin D3 in the skin of poikilothermic animals.

  1995cited by this paper
• Principles of CDK regulation

  1995cited by this paper
• Structure-function relationships in the vitamin D endocrine system.

  1995cited by this paper
• Direct interaction of Gadd45 with PCNA and evidence for competitive interaction of Gadd45 and p21Waf1/Cip1 with PCNA.

  1995cited by this paper
• Difference and similarity of DNA sequence recognized by VDR homodimer and VDR/RXR heterodimer.

  1994cited by this paper
• Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.

  1994cited by this paper
• Stimulation of GAL4 derivative binding to nucleosomal DNA by the yeast SWI/SNF complex.

  1994cited by this paper
• Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen.

  1994cited by this paper
• DNA sequences that act as high affinity targets for the vitamin D3 receptor in the absence of the retinoid X receptor.

  1994cited by this paper

• Diagnostic Potential of CD44, CD133, and VDR in Epithelial Ovarian Tumors: Association with Histopathology Parameters

  2025cites this paper
• Association between MTHFR polymorphisms and vitamin D status in infertile women: a mediation analysis

  2025cites this paper
• Vitamin‐Engineered Nanoplatforms in Precision Oncology: Integrating Immunotherapy, Delivery Systems, and Theranostics

  2025cites this paper
• Pan-Cancer Analysis Confirms the Prognostic and Immunological Implications of the 1,25-Dihydroxy Vitamin D3 Receptor in Cervical Squamous Cell Carcinoma

  2024cites this paper
• Nonlinear correlation between serum vitamin D levels and the incidence of endometrial polyps in infertile women.

  2024cites this paper
• Vitamin D and its binding protein in patients with leiomyomas

  2024cites this paper
• Role of vitamin D in targeting cancer and cancer stem cell populations and its therapeutic implications

  2022cites this paper
• Total Meat Intake is Associated with Life Expectancy: A Cross-Sectional Data Analysis of 175 Contemporary Populations

  2022cites this paper
• Vitamin D ve Antikanserojenik Etkileri

  2021cites this paper
• Evaluation of vitamin D receptor expression in uterine leiomyoma and nonneoplastic myometrial tissue: a cross‐sectional controlled study

  2021cites this paper
• Role of vitamin D3 in selected malignant neoplasms.

  2020cites this paper
• Vitamin D Exposure and Ovarian Cancer Risk and Prognosis

  2020cites this paper
• The role of vitamin D3 in signaling pathways – potential anticancer properties of calcitriol and its analogues

  2019cites this paper
• Low fertility may be a significant determinant of ovarian cancer worldwide: an ecological analysis of cross- sectional data from 182 countries

  2018cites this paper
• Expression of vitamin D receptor in clear cell papillary renal cell carcinoma.

  2018cites this paper
• Vitamin D3 stimulates embryonic stem cells but inhibits migration and growth of ovarian cancer and teratocarcinoma cell lines

  2016cites this paper
• Race/Ethnicity-Specific Association of Vitamin D and Global DNA Methylation: Cross-Sectional and Interventional Findings

  2016cites this paper
• Polymorphic variants in the vitamin D pathway genes and the risk of ovarian cancer among non-carriers of BRCA1/BRCA2 mutations.

  2016cites this paper
• Suppression of epithelial ovarian cancer invasion into the omentum by 1α,25-dihydroxyvitamin D3 and its receptor.

  2015cites this paper
• Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition

  2015cites this paper
• Mechanistic Effects of Calcitriol in Cancer Biology

  2015cites this paper
• Vitamin D and the epigenome

  2014cites this paper
• Vitamin D suppresses leptin stimulation of cancer growth through microRNA.

  2014cites this paper
• Growth through MicroRNA-498 Cancer Telomerase Expression and Human 1,25-Dihydroxyvitamin D3 Suppresses

  2014cites this paper
• Pharmacological effects of vitamin D and its analogs: recent developments.

  2014cites this paper
• Vitamin D Receptor Gene BsmI and FokI Polymorphisms in Relation to Ovarian Cancer Risk in the Polish Population

  2013cites this paper
• 24-Hydroxylase in cancer: impact on vitamin D-based anticancer therapeutics.

  2013cites this paper
• Serum vitamin D3 level inversely correlates with uterine fibroid volume in different ethnic groups: a cross-sectional observational study

  2013cites this paper
• Serum vitamin D 3 level inversely correlates with uterine fibroid volume in different ethnic groups : a cross-sectional observational study

  2013cites this paper
• 1,25-Dihydroxyvitamin D3 Suppresses Telomerase Expression and Human Cancer Growth through MicroRNA-498*

  2012cites this paper
• The coupling of epidermal growth factor receptor down regulation by 1alpha,25-dihydroxyvitamin D3 to the hormone-induced cell cycle arrest at the G1-S checkpoint in ovarian cancer cells.

  2011cites this paper
• Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells

  2011cites this paper
• Epidemiological study of the role of vitamin D in the aetiology of ovarian cancer

  2011cites this paper
• 19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cells.

  2011cites this paper
• Casting light on 25-hydroxyvitamin D deficiency in ovarian cancer: a study from the NHANES.

  2010cites this paper
• 25-Hydroxyvitamin D3 1alpha-hydroxylase splice variants in benign and malignant ovarian cell lines and tissue.

  2009cites this paper
• Effects of platelet-derived growth factor, vitamin D and parathyroid hormone on osteoblasts derived from cancer patients on chronic bisphosphonate therapy.

  2009cites this paper
• Inhibition of hepatocellular cancer by EB1089: in vitro and in vive study.

  2008cites this paper
• CHAPTER 13 – Vitamin D: Biology, Action, and Clinical Implications

  2008cites this paper
• Epigenetic inhibition of nuclear receptor small heterodimer partner is associated with and regulates hepatocellular carcinoma growth.

  2008cites this paper
• Vitamin D analogs: therapeutic applications and mechanisms for selectivity.

  2008cites this paper
• Motif detection in vertebrates based on comparative genomics

  2007cites this paper
• A vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model.

  2007cites this paper